Tudor Investment Corp’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-71,893
| Closed | -$831K | – | 3488 |
|
|
2025
Q3 | $831K | Buy |
71,893
+60,099
| +510% | +$704K | ﹤0.01% | 2389 |
|
|
2025
Q2 | $144K | Sell |
11,794
-36,487
| -76% | -$459K | ﹤0.01% | 3136 |
|
|
2025
Q1 | $692K | Buy |
48,281
+15,710
| +48% | +$245K | ﹤0.01% | 2075 |
|
|
2024
Q4 | $519K | Buy |
+32,571
| New | +$645K | ﹤0.01% | 2210 |
|
|
2024
Q3 | – | Sell |
-30,762
| Closed | -$613K | – | 2695 |
|
|
2024
Q2 | $613K | Sell |
30,762
-45,094
| -59% | -$878K | ﹤0.01% | 1714 |
|
|
2024
Q1 | $1.51M | Buy |
+75,856
| New | +$1.47M | 0.01% | 1156 |
|
|
2023
Q4 | – | Sell |
-22,030
| Closed | -$445K | – | 2360 |
|
|
2023
Q3 | $445K | Buy |
+22,030
| New | +$499K | ﹤0.01% | 1733 |
|
|
2023
Q1 | – | Sell |
-52,262
| Closed | -$1.41M | – | 2393 |
|
|
2022
Q4 | $1.41M | Sell |
52,262
-14,272
| -21% | -$349K | 0.03% | 849 |
|
|
2022
Q3 | $1.45M | Buy |
66,534
+38,819
| +140% | +$1.01M | 0.03% | 689 |
|
|
2022
Q2 | $758K | Sell |
27,715
-5,463
| -16% | -$157K | 0.02% | 1046 |
|
|
2022
Q1 | $1.11M | Buy |
33,178
+18,890
| +132% | +$608K | 0.03% | 854 |
|
|
2021
Q4 | $495K | Buy |
+14,288
| New | +$462K | 0.01% | 1473 |
|
|
2021
Q3 | – | Sell |
-20,786
| Closed | -$756K | – | 2441 |
|
|
2021
Q2 | $756K | Buy |
+20,786
| New | +$860K | 0.01% | 984 |
|
|
2020
Q4 | – | Sell |
-11,568
| Closed | -$384K | – | 1328 |
|
|
2020
Q3 | $384K | Sell |
11,568
-13,797
| -54% | -$441K | 0.02% | 915 |
|
|
2020
Q2 | $745K | Buy |
25,365
+15,728
| +163% | +$455K | 0.04% | 579 |
|
|
2020
Q1 | $260K | Buy |
+9,637
| New | +$288K | 0.02% | 727 |
|
|
2017
Q3 | – | Sell |
-10,845
| Closed | -$426K | – | 1084 |
|
|
2017
Q2 | $426K | Sell |
10,845
-3,493
| -24% | -$132K | 0.01% | 624 |
|
|
2017
Q1 | $546K | Buy |
14,338
+6,078
| +74% | +$237K | 0.02% | 638 |
|
|
2016
Q4 | $305K | Sell |
8,260
-14,601
| -64% | -$522K | 0.01% | 1016 |
|
|
2016
Q3 | $792K | Buy |
22,861
+6,182
| +37% | +$217K | 0.02% | 504 |
|
|
2016
Q2 | $542K | Buy |
+16,679
| New | +$511K | 0.01% | 785 |
|
|
2015
Q4 | – | Sell |
-7,125
| Closed | -$203K | – | 1630 |
|
|
2015
Q3 | $203K | Sell |
7,125
-16,611
| -70% | -$579K | 0.01% | 1333 |
|
|
2015
Q2 | $961K | Buy |
23,736
+11,242
| +90% | +$505K | 0.03% | 443 |
|
|
2015
Q1 | $615K | Sell |
12,494
-316,614
| -96% | -$14.7M | 0.02% | 616 |
|
|
2014
Q4 | $15M | Buy |
+329,108
| New | +$12.9M | 0.52% | 18 |
|
Other funds holding AVNS
AC
Tudor Investment Corp's AVNS Position: Q4 2025 in Review
Tudor Investment Corp sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 71,893 shares — an estimated $831K sold.
Tudor Investment Corp first reported a position in AVNS in Q4 2014 and held it in 25 quarters. The position peaked at $15M in Q4 2014. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.
- Tudor Investment Corp reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
- Tudor Investment Corp sold 71,893 Avanos Medical shares in Q4 2025, an estimated $831K.
- Tudor Investment Corp first reported a position in Avanos Medical in Q4 2014 and held it in 25 quarters.
- Tudor Investment Corp's Avanos Medical position peaked at $15M in Q4 2014.
- 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.
Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.